About Gnosis by Lesaffre

Gnosis was founded in 2018 with the acquisition of Gnosis Advanced Biotech by the Lesaffre Group, which then merged this entity with Lesaffre Human Care. They are an innovative biotechnology company, that is specialized in developing, manufacturing, and selling active ingredients, nutritional yeasts, probiotics, and prebiotics, for pharmaceutical and nutraceutical industries.

Their expertise in human health and wellbeing is the result of Lesaffre’s expertise in yeast production and fermentation, Gnosis Biotech’s innovative knowledge of active molecules for human health care, and, most recently, the scientific expertise of NattoPharma.

Gnosis Advanced Biotech started in 1989 as a small research laboratory in Cairate, Italy, and grew to become a leading producer of active pharmaceutical ingredients (APIs) using fermentation processes. With over 250 employees, the company now has a global presence and is committed to research and innovation. Its focus on producing high-quality APIs has contributed to its success, and its dedication to fermentation processes has allowed it to develop a wide range of compounds with high efficacy and safety profiles. Gnosis Advanced Biotech's growth trajectory and contributions to the biotech industry position it well for continued success in the future.